Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Remember: RG' goal is 50% institutional ownership

Remember: RG' goal is 50% institutional ownership

posted on Sep 26, 2009 06:01AM

According to a mail exchange I had with IBIS some months ago they will re-start their efforts to find new investors in September.

Thus my guess (and hope) is we'll see more such days like yesterday with the SP rising without news, just because new "entities" start investing.

Enjoy your weekend - glta

Share
New Message
Please login to post a reply